| 11/28/2011 |
|
IsoRay Ships First Gliasite® Brain Cancer Treatment |
| 11/22/2011 |
|
IsoRay Receives Final Regulatory Approval for Gliasite® Brain Cancer Treatment |
| 11/15/2011 |
|
Isoray, Inc. Reports First Quarter Results Citing Growth in New Cancer Treatment Revenues |
| 11/03/2011 |
|
IsoRay Announces Major International Distribution Agreement for Gliasite |
| 10/13/2011 |
|
ISORAY Announces Financing for $2.3 Million to Advance its New Emerging Cancer Solutions for Brain, Lung and Breast Cancer |
| 10/10/2011 |
|
MD Anderson Cancer Center Initiates Orders of Isoray's Cesium-131 for Intermediate Risk Prostate Cancer Study |
| 09/28/2011 |
|
New Products and Sales Initiated in FY2011 Final Quarter Expected to Power Growth |
| 09/26/2011 |
|
Metastasized Brain Cancer Treated with Isoray's Cesium-131 in World's First at N.Y. Presbyterian/Weill Cornell Medical Center |
| 09/12/2011 |
|
FDA Clears IsoRay's GliaSite(R) Treatment for Brain Cancer |
| 08/22/2011 |
|
Adoption of Isoray's Cesium-131 Treatment for Lung Cancer gains momentum using Da Vinci Robotics System |
| 08/15/2011 |
|
IsoRay announces World's first Cesium-131 Treatment for Gynecological Cancer |
| 08/09/2011 |
|
Archbold Pioneering Treatment for Lung Cancer |
| 07/12/2011 |
|
Isoray announces World's first Cesium-131 Treatment for Lung Cancer using Da Vinci Robotic Surgery System |
| 06/20/2011 |
|
Isoray launches National Dual Therapy Study for High Risk Prostate Cancer focusing on Company's CESIUM-131 Internal Radiation Isotope |
| 06/07/2011 |
|
Isoray acquires Exclusive Worldwide License for Liquid Iodine Iotrex® for Gliasite® Brain Cancer Treatment |
| 05/17/2011 |
|
Matt Kaplan, Ladenburg Research |
| 05/16/2011 |
|
IsoRay, Inc. Reports Gains in Third Quarter Fiscal Year 2011 Results |
| 04/12/2011 |
|
IsoRay, Inc. Receives $500,000 in Additional Financing |
| 02/16/2011 |
|
Initiation Report LifeTech Capital |
| 12/15/2011 |
|
IsoRay, Inc. Announces Second Quarter Fiscal Year 2011 Results |
| 11/23/2010 |
|
IsoRay, Inc. Announces Financing Commitment of $4,325,000 |
| 11/15/2010 |
|
IsoRay, Inc. Announces First Quarter Fiscal Year 2011 Results |
| 11/08/2010 |
|
IsoRay Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer |
| 10/13/2010 |
|
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study |
| 10/07/2010 |
|
Isoray Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer |
| 09/28/2010 |
|
IsoRay, Inc. Announces Fiscal Year 2010 Results |
| 06/23/2010 |
|
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device |
| 06/15/2010 |
|
More Centers Adopt IsoRay's Revolutionary Isotope for the Treatment of Lung Cancers |
| 02/18/2010 |
|
IsoRay, Inc. Corrected Second Quarter Results |
| 02/16/2010 |
|
IsoRay, Inc. Reports Second Quarter Results |
| 01/27/2010 |
|
IsoRay, Inc Hires Vice President of Research and Development |
| 01/25/2010 |
|
IsoRay, Inc Announces It Has Provided Seeds to Canada for Research Initiatives to Expand the Use of Cesium-131 for New Cancer Applications |
| 01/21/2010 |
|
IsoRay, Inc Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center |
| 12/03/2009 |
|
IsoRay, Inc Announces Iodine Distribution Agreement with GE Subsidiary, Oncura |
| 11/18/2009 |
|
IsoRay, Inc Announces Distribution Agreement in Canada |
| 11/16/2009 |
|
IsoRay, Inc. Reports First Quarter Results |
| 10/29/2009 |
|
IsoRay Announces World's First Cesium-131 Lung Implants Performed at Cornell Medical Center |
| 09/28/2009 |
|
IsoRay Announces Cornell Medical Center Adopts Cesium-131 to Treat Head and Neck Cancer |
| 09/24/2009 |
|
IsoRay Inc. Announces Fiscal Year 2009 Results |
| 08/18/2009 |
|
IsoRay Announces FDA Clearance Supporting Enhanced Loading and Delivery Methods for the Treatment of Lung, Head and Neck, and Other Tumors |
| 07/27/2009 |
|
IsoRay Announces First Head And Neck Cancer Treated With Cesium-131 |
| 05/19/2009 |
|
IsoRay, Inc. Reports Third Quarter Results
|
| 05/07/2009 |
|
IsoRay Announces Expansion into Canadian Brachytherapy Market
|
| 02/17/2009 |
|
IsoRay Inc. Reports Second Quarter Results
|
| 11/24/2008 |
|
IsoRay Hires New VP of Business Development in Charge of Sales
|
| 11/20/2008 |
|
Treatment guidelines for ProxcelanTM (Cesium-131) brachytherapy seeds highlighted in Brachytherapy
|
| 11/13/2008 |
|
IsoRay, Inc. Reports First Quarter Results
|
| 11/06/2008 |
|
IsoRay Inc. Announces First Quarter Earnings Release Date and Conference Call
|
| 08/20/2008 |
|
IsoRay Inc. Announces Fourth Quarter & Fiscal Year 2008 Results
|
| 08/12/2008 |
|
IsoRay Inc. Announces Fourth Quarter & Fiscal Year 2008 Earnings Release Date and Conference Call
|
| 07/24/2008 |
|
IsoRay Receives No List of Observations (form FDA 483) in FDA Inspection
|
| 06/12/2008 |
|
IsoRay Conducts Second Proxcelan Cs-131 Workshop at Chicago Prostate Cancer Center in 2008
|
| 06/03/2008 |
|
IsoRay, Inc. Announces Authorization of Stock Repurchase Plan
|
| 05/13/2008 |
|
IsoRay, Inc. Reports Third Quarter Results
|
